Vendor Management and Oversight of Clinical Trials
Discover practical guidance on vendor management, including vendor selection, risk assessment, and oversight to ensure trial success.
Discover practical guidance on vendor management, including vendor selection, risk assessment, and oversight to ensure trial success.
Breaking down barriers to participation in clinical research has long been a challenge, affecting every aspect of the industry. As
This white paper outlines a data strategy specific to an organization’s unique needs and allows for adjustments as the organization grows and evolves.
In a recent webinar, Advarra experts Emily Eldh and Ben Shankle provided insights and information in Remote Monitoring: Study Compliance
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
Developing an investigational new drug (IND) application is a big milestone for organizations, especially small companies bringing their first drug
To maintain Part 11 compliance, research sites must validate electronic systems storing FDA-regulated records, safeguarding data integrity and accuracy.
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
In a recent blog, we described the complexity and uniqueness of Phase I clinical trials, outlining the fact that some
A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts
Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.
Decentralization is one arrow in the quiver to modernize clinical trials.[1] Yet, owing to the varied approaches and possible components